Media
NVHR Blog
Disrupting Viral Hepatitis Stigma in Everyday Life
You don’t need to be an expert to interrupt stigma, and it’s a muscle anyone can grow with practice. Here are some ways to disrupt the flow of stigma when you encounter it.
NVHR Talks: Hep B Birth Dose
The NVHR team discusses the history and evidence behind the recommendation for all newborns to receive a birth dose of hepatitis B vaccine, and how an upcoming CDC advisory committee meeting might upend longstanding practice.
New Resource: Hepatitis C Care in Jails
Our colleagues at Harvard Law School’s Center for Health Law and Policy Innovation (CHLPI) have produced a new resource, Strategies to Improve Hepatitis C Care in Jails: A tool for advocates seeking to improve availability and uptake of HCV screening and treatment with direct-acting antivirals in jails. From the introduction: As plans to eliminate hepatitis…
From Fingerstick to Cure: Factors to Consider Around Adoption and Implementation of Hepatitis C RNA Point-of-Care Testing
In June 2024, the FDA authorized the Cepheid Xpert HCV test to detect hepatitis C virus (HCV) RNA, marking a significant milestone for the viral hepatitis community in the U.S. This first-ever HCV RNA point-of-care (POC) test runs on the GeneXpert Xpress system in CLIA-waived settings. It detects HCV RNA in adults aged 22 years…